US Patent Issued to BioTheryX on Jan. 13 for "PDE4 inhibitors, pharmaceutical compositions, and therapeutic applications" (California Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,612, issued on Jan. 13, was assigned to BioTheryX Inc. (San Diego).

"PDE4 inhibitors, pharmaceutical compositions, and therapeutic applications" was invented by Kyle W.H. Chan (San Diego), Paul E. Erdman (San Diego), Leah M. Fung (San Diego), David Aaron Hecht (Chula Vista, Calif.), Frank Mercurio (Rancho Santa Fe, Calif.) and Robert W. Sullivan (Vista, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are phosphodiesterase 4 (PDE4) inhibitors, e.g., a compound of Formula (I) or (II), and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more sympto...